Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Wheeler, Koral V. | Irimia, Andrei | Braskie, Meredith N.
Article Type: Review Article
Abstract: Cerebral amyloid angiopathy (CAA) is characterized by amyloid-β aggregation in the media and adventitia of the leptomeningeal and cortical blood vessels. CAA is one of the strongest vascular contributors to Alzheimer’s disease (AD). It frequently co-occurs in AD patients, but the relationship between CAA and AD is incompletely understood. CAA may drive AD risk through damage to the neurovascular unit and accelerate parenchymal amyloid and tau deposition. Conversely, early AD may also drive CAA through cerebrovascular remodeling that impairs blood vessels from clearing amyloid-β. Sole reliance on autopsy examination to study CAA limits researchers’ ability to investigate CAA’s natural disease …course and the effect of CAA on cognitive decline. Neuroimaging allows for in vivo assessment of brain function and structure and can be leveraged to investigate CAA staging and explore its associations with AD. In this review, we will discuss neuroimaging modalities that can be used to investigate markers associated with CAA that may impact AD vulnerability including hemorrhages and microbleeds, blood-brain barrier permeability disruption, reduced cerebral blood flow, amyloid and tau accumulation, white matter tract disruption, reduced cerebrovascular reactivity, and lowered brain glucose metabolism. We present possible areas for research inquiry to advance biomarker discovery and improve diagnostics. Show more
Keywords: Alzheimer’s disease, amyloid, cerebral amyloid angiopathy, microbleeds, neuroimaging, tau, vascular dysfunction
DOI: 10.3233/JAD-230553
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1479-1502, 2024
Authors: Wei, Guoliang | Tian, Xuelong | Yang, Hong | Luo, Yinpei | Liu, Guisong | Sun, Shuqing | Wang, Xing | Wen, Huizhong
Article Type: Review Article
Abstract: The auditory afferent pathway as a clinical marker of Alzheimer’s disease (AD) has sparked interest in investigating the relationship between age-related hearing loss (ARHL) and AD. Given the earlier onset of ARHL compared to cognitive impairment caused by AD, there is a growing emphasis on early diagnosis and intervention to postpone or prevent the progression from ARHL to AD. In this context, auditory evoked potentials (AEPs) have emerged as a widely used objective auditory electrophysiological technique for both the clinical diagnosis and animal experimentation in ARHL due to their non-invasive and repeatable nature. This review focuses on the application of …AEPs in AD detection and the auditory nerve system corresponding to different latencies of AEPs. Our objective was to establish AEPs as a systematic and non-invasive adjunct method for enhancing the diagnostic accuracy of AD. The success of AEPs in the early detection and prediction of AD in research settings underscores the need for further clinical application and study. Show more
Keywords: Age-related hearing loss, Alzheimer’s disease, auditory evoked potentials, auditory nerve system
DOI: 10.3233/JAD-230822
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1503-1517, 2024
Authors: Cui, Xiaoyan | Wang, Junqiao | Wu, Bei | Zhao, Qianhua | Tang, Xueting | Wang, Jing
Article Type: Review Article
Abstract: Background: Dementia occurring before age 65 is known as young-onset dementia (YOD), with Alzheimer’s disease being the most common type. YOD poses unique challenges for persons and families, impacting their working-age years and family responsibilities. Person-centered interventions and services are essential to improve their quality of life and social engagement. Objective: This study aims to synthesize non-pharmacological interventions for persons with YOD and their families to inform future targeted interventions. Methods: We conducted a systematic literature search across four databases: PubMed, PsycINFO, Scopus, and CINAHL. The included articles were carefully screened, categorized, and …synthesized by following Arksey and O’Malley’s five stages framework. Results: We included 20 studies reported in 24 papers, with 11 studies (14 papers) on persons with YOD and nine studies (10 papers) on families. Quantitative intervention results vary, but qualitative interviews show positive feedback. Stakeholders provided positive evaluations, stating these interventions provided a sense of normalcy, facilitated communication among families, enhanced the independence of persons with YOD, and improved the families’ caregiving self-efficacy, thereby reducing care burden and psychological distress. The heterogeneity among the studies posed integration challenges. Conclusions: Interventions for YOD can improve the quality of life for both persons with YOD and their families. More extensive intervention studies are urgently needed, especially in developing countries, with a focus on family-centered and life course perspectives. In future intervention research design, a more extensive incorporation of stakeholder involvement is essential for successful implementation. Moreover, the integration of new technologies shows promise as a potential avenue for intervention advancement. Show more
Keywords: Alzheimer’s disease, early-onset dementia, non-pharmacological interventions, review, young-onset dementia
DOI: 10.3233/JAD-231006
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1519-1531, 2024
Authors: Anlacan, Veeda Michelle M. | Lanuza, Pamela Danielle T. | Sanchez, Anna Anjelica R. | Jamora, Roland Dominic G.
Article Type: Review Article
Abstract: Background: Dementia prevalence is increasing in low- and middle-income countries such as the Philippines. Objective: This study aimed to give an overview of dementia care in the Philippines and to identify gaps in terms of local epidemiology, research, financial coverage, diagnostics, pharmacotherapy, manpower, and caregiver support. Methods: This scoping review was conducted using the Preferred Reporting Items for Systematic reviews and Meta-analysis guidelines extension for scoping reviews. Six international and two local databases, and government and non-government websites were searched. Data published in the English or Filipino language on dementia epidemiology, research, diagnostics, …management, manpower, and training were extracted from the earliest indexed record until June 2022. Results: The prevalence of dementia in the Philippines is high and research output on all aspects of dementia is low. Cost is a major barrier as health care coverage is limited, with reliance mainly on out-of-pocket payments, leading to challenges in the proper diagnosis and treatment of dementia. There is a low specialist-to-population ratio, with shortages beyond manpower and training. Conclusions: Gaps in dementia care include limited published local data, high healthcare costs, inadequate health financing, and limited manpower. Show more
Keywords: Alzheimer’s disease, dementia, health status, practice gaps
DOI: 10.3233/JAD-230845
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1533-1543, 2024
Authors: Chang, Haiqing | Chen, Erya | Zhu, Tao | Liu, Jin | Chen, Chan
Article Type: Review Article
Abstract: Coronary artery disease is a prevalent ischemic disease that results in insufficient blood supply to the heart muscle due to narrowing or occlusion of the coronary arteries. Various reperfusion strategies, including pharmacological thrombolysis and percutaneous coronary intervention, have been developed to enhance blood flow restoration. However, these interventions can lead to myocardial ischemia/reperfusion injury (MI/RI), which can cause unpredictable complications. Recent research has highlighted a compelling association between MI/RI and cognitive function, revealing pathophysiological mechanisms that may explain altered brain cognition. Manifestations in the brain following MI/RI exhibit pathological features resembling those observed in Alzheimer’s disease (AD), implying a potential …link between MI/RI and the development of AD. The pro-inflammatory state following MI/RI may induce neuroinflammation via systemic inflammation, while impaired cardiac function can result in cerebral under-perfusion. This review delves into the role of extracellular vesicles in transporting deleterious substances from the heart to the brain during conditions of MI/RI, potentially contributing to impaired cognition. Addressing the cognitive consequence of MI/RI, the review also emphasizes potential neuroprotective interventions and pharmacological treatments within the MI/RI model. In conclusion, the review underscores the significant impact of MI/RI on cognitive function, summarizes potential mechanisms of cardio-cerebral communication in the context of MI/RI, and offers ideas and insights for the prevention and treatment of cognitive dysfunction following MI/RI. Show more
Keywords: Alzheimer’s disease, cognitive function, coronary artery disease, extracellular vesicles, myocardial ischemia/reperfusion injury, neuroinflammation, neuroprotective interventions
DOI: 10.3233/JAD-230886
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1545-1570, 2024
Authors: Armstrong, Melissa J. | Barnes, Lisa L.
Article Type: Review Article
Abstract: Dementia with Lewy bodies (DLB) is one of the most common degenerative dementias after Alzheimer’s disease (AD) dementia. DLB is under-diagnosed across populations but may be particularly missed in older Black adults. The object of this review was to examine key features of DLB and potential associations with race in order to hypothesize why DLB may be under-diagnosed in Black adults in the U.S. In terms of dementia, symptoms associated with high rates of co-pathology (e.g., AD, vascular disease) in older Black adults may obscure the clinical picture that might suggest Lewy body pathology. Research also suggests that clinicians may …be predisposed to give AD dementia diagnoses to Black adults, potentially missing contributions of Lewy body pathology. Hallucinations in Black adults may be misattributed to AD or primary psychiatric disease rather than Lewy body pathology. Research on the prevalence of REM sleep behavior in diverse populations is lacking, but REM sleep behavior disorder could be under-diagnosed in Black adults due to sleep patterns or reporting by caregivers who are not bed partners. Recognition of parkinsonism could be reduced in Black adults due to clinician biases, cultural effects on self-report, and potentially underlying differences in the frequency of parkinsonism. These considerations are superimposed on structural and systemic contributions to health (e.g., socioeconomic status, education, structural racism) and individual-level social exposures (e.g., social interactions, discrimination). Improving DLB recognition in Black adults will require research to investigate reasons for diagnostic disparities and education to increase identification of core symptoms in this population. Show more
Keywords: Alzheimer’s disease, Black or African American, dementia, Lewy body disease, parkinsonian disorders, race factors, racial groups, social determinants of health
DOI: 10.3233/JAD-231177
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1571-1580, 2024
Authors: Finch, Caleb E. | Burstein, Stanley M.
Article Type: Review Article
Abstract: Background: The possibility that Alzheimer’s disease and related dementias (ADRD) is a modern disease arises from the minimal mention of advanced cognitive decline by ancient Greeks and Romans, who were mainly concerned with the physical frailties of older ages. Objective: Because standard medical histories of elderly health lacked mention of cognitive decline, we examined texts by Greek and Roman authors that mentioned memory loss and dementia. Methods: Primary texts of Greco-Roman authors, 8th century BCE into the 3rd century CE, that mentioned cognitive decline were identified and critically evaluated. Secondary sources were excluded. …Results: No ancient account of cognitive loss is equivalent to modern clinical data. The term dementia was occasionally used in antiquity, but not invariably linked to old age. Ancient Greeks and Romans expected intellectual competence beyond age 60. While some memory loss was acknowledged, we found only four accounts of severe cognitive loss that might represent ADRD. The possibility of modest ADRD prevalence in ancient Greece and Rome is consistent with its low prevalence in the Tsimane of Bolivia. These contemporary Amerindians live under conditions of high mortality from frequent infections and minimal cardiovascular disease with physically demanding lives. Tsimane after age 60 had increased mild cognitive impairment; the few cases of dementia were not clinically consistent with AD. Conclusions: The modern ‘epidemic level’ of advanced dementias was not described among ancient Greco-Roman elderly. The possible emergence of advanced ADRD in the Roman era may be associated with environmental factors of air pollution and increased exposure to lead. Further historical analysis may formulate critical hypotheses about the modernity of high ADRD prevalence. Show more
Keywords: Aging, Alzheimer’s disease, dementia, lead, memory
DOI: 10.3233/JAD-230993
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1581-1588, 2024
Authors: Li, Jianhong | Yang, Minguang | Wei, Renli | Cao, Yue | Fan, Xu | Zhang, Shenghang
Article Type: Systematic Review
Abstract: Background: Alzheimer’s disease (AD) is a neurodegenerative disease with insidious onset. Identifying candidate predictors to forecast AD dementia risk before disease onset is crucial for early diagnosis and treatment. Objective: We aimed to assess the predictive ability of blood neurofilament light (NfL) chain in anticipating cognitive decline in the AD continuum. Methods: We systematically searched PubMed, Web of Science, and Embase from inception until April 7, 2023. Longitudinal observational studies examining the association between baseline blood NfL and cognitive decline or clinical disease conversion were included based on inclusion/exclusion criteria. The final effect size was represented …by adjusted hazard ratios (HR) or standardized beta (s.β) coefficients with a 95% confidence interval (CI). Results: A total of 2,862 articles were identified, and 26 studies were included in this meta-analysis. The results indicated that baseline blood NfL could predict cognitive decline, with MMSE [s.β= –0.17, 95% CI (–0.26, –0.07)]; PACC [s.β= –0.09, 95% CI (–0.16, –0.03)]; ADAS-cog [s.β= 0.21, 95% CI (0.13, 0.29)]; CDR-SOB [s.β= 0.27, 95% CI (0.03, 0.50)]; Global cognitive composite [s.β= –0.05, 95% CI (–0.08, –0.01)]; Memory subdomain [s.β= –0.06, 95% CI (–0.09, –0.03)]; Language subdomain [s.β= –0.07, 95% CI (–0.10, –0.05)]; Executive function subdomain [s.β= –0.02, 95% CI (–0.03, –0.01)]; Visuospatial subdomain [s.β= –0.06, 95% CI (–0.08, –0.04)]. Additionally, baseline blood NfL could predict disease progression (conversion from CU/SCD/MCI to MCI/AD) in the AD continuum [Adjust HR = 1.32, 95% CI (1.12, 1.56)]. Conclusions: Baseline blood NfL demonstrated predictive capabilities for global cognition and its memory, language, executive function, visuospatial subdomains decline in the AD continuum. Moreover, it exhibited the potential to predict disease progression in non-AD dementia participants. Show more
Keywords: Alzheimer’s disease, biomarkers, blood neurofilament light chain, cognitive decline, disease conversion
DOI: 10.3233/JAD-231080
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1589-1620, 2024
Authors: Caban-Holt, Allison | Cuccaro, Michael L. | Lloyd, Shawnta L. | Starks, Takiyah D. | Adams, Larry D. | Ford, Tayla | Haines, Jonathan L. | Beecham, Gary | Reitz, Christiane | Vance, Jeffery M. | Pericak-Vance, Margaret A. | Byrd, Goldie S.
Article Type: Short Communication
Abstract: The objective of this study was to investigate attitudes toward brain donation and perceptions of medical research that influence brain donation among African Americans. Cross-sectional surveys were administered to African American community members (n = 227). Findings indicate that only 27% of respondents were willing to donate their brain. As medical mistrust was not found to be a significant barrier to research participation, there may be opportunity to increase brain donation by providing information about Alzheimer’s disease and brain donation to potential donors and their families so that informed decisions about participating in research can be made.
Keywords: Alzheimer’s disease, Black or African American, brain donation, dementia, medical mistrust, recruitment, research participation
DOI: 10.3233/JAD-230461
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1621-1627, 2024
Authors: Valencia-Olvera, Ana C. | Balu, Deebika | Moore, Annabelle | Shah, Maitri | Ainis, Rebecca | Xiang, Bingtao | Saleh, Yaseen | Cai, Dongming | LaDu, Mary Jo | Tai, Leon M.
Article Type: Short Communication
Abstract: APOE2 lowers Alzheimer’s disease (AD) risk; unfortunately, the mechanism remains poorly understood and the use of mice models is problematic as APOE2 homozygosity is associated with hyperlipidemia. In this study, we developed mice that are heterozygous for APOE2 and APOE3 or APOE4 and overexpress amyloid-β peptide (Aβ) (EFAD) to evaluate the effect of APOE2 dosage on Aβ pathology. We found that heterozygous mice do not exhibit hyperlipidemia. Hippocampal but not cortical levels of soluble Aβ42 followed the order E2/2FAD > E2/3FAD≤E3/3FAD and E2/2FAD > E2/4FAD < E4/4FAD without an effect on insoluble Aβ42 . These findings offer initial insights …on the impact of APOE2 on Aβ pathology. Show more
Keywords: Aβ42, Alzheimer’s disease, APOE2, hyperlipidemia, plasma lipoproteins
DOI: 10.3233/JAD-231210
Citation: Journal of Alzheimer's Disease, vol. 97, no. 4, pp. 1629-1639, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]